This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Greenberg, B. H. Articles by Chatterjee, K. Search for Related Content PubMed PubMed Citation Articles by Greenberg, B. H. Articles by Chatterjee, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HYDRALAZINE HYDROCHLORIDE

Circulation, Vol 58, 273-279, Copyright © 1978 by American Heart Association

ARTICLES

Beneficial effects of hydralazine in severe mitral regurgitation

BH Greenberg, BM Massie, BH Brundage, EH Botvinick, WW Parmley and K Chatterjee

The severity of mitral regurgitation is, in part, determined by aortic impedance to left ventricular outflow. Sodium nitroprusside acutely decreases regurgitant flow, but the importance of its dual vasodilating effects, the lowering of peripheral vascular resistance and increasing of venous capacitance, is unclear. We studied the hemodynamic response to intravenous hydralazine, which selectively acts on the arteriolar resistance bed, in 10 patients with severe mitral regurgitation. Hydralazine produced a 50% increase in forward stroke volume (22 +/- 2 to 33 +/- 3 ml/m2, P less than 0.001) and a 33% reduction in regurgitant stroke volume (40 +/- 6 to 27 +/- 6 ml/m2, P less than 0.001), with a resultant fall in pulmonary capillary wedge v wave and mean pressures. Unlike nitroprusside, it did not alter left ventricular end-diastolic volume or pressure. Oral hydralazine maintained this hemodynamic improvement for at least 48 hours and, in three patients, provided more sustained clinical improvement. We conclude that hydralazine, by virtue of its selective lowering of aortic impedance, reduces the amount of mitral regurgitation and thus may be a useful mode of interim or chronic therapy in selected patients.

This article has been cited by other articles:

				L. B. Rosario, L. W. Stevenson, S. D. Solomon, R. T. Lee, and S. C. Reimold The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice size J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1819 - 1824. [Abstract] [Full Text] [PDF]

				L. Gould, C. Gopalaswamy, F. Chandy, and O. Abdou Noninvasive Assessment of Left Ventricular Wall Stress in Chronic Congestive Heart Failure Patients Angiology, February 1, 1983; 34(2): 111 - 118. [Abstract] [PDF]

				L. Gould, V.R. Reddy, S. Patel, G.I. Gomes, and W. H. Becker Noninvasive Assessment of Load Reduction in Chronic Congestive Heart Failure Patients Angiology, August 1, 1981; 32(8): 552 - 560. [PDF]

				L. Gould, C.V.R. Reddy, Bujung Zen, and B.K. Singh Effect of Nitroglycerin Ointment on Hemodynamics in Patients With Mitral Insufficiency Angiology, October 1, 1980; 31(10): 677 - 685. [Abstract] [PDF]